Established in 2013, Leadgene Biomedical, Inc. is a company specialising in immunotechnology and especially in the technologies of antigen prediction and design and the development of monoclonal antibody and protein. We are also involved in the development of antibody drug candidates and companion diagnostics.
We focus on the development of monoclonal antibody and application platforms, including IVD kit development and antibody drug development, as well as related reagents for both academic research and in vitro diagnostics use. We have expanded our expertise to several fields, providing comprehensive technology from gene to protein, antibody applications, and various immunoassay platforms. In addition, we strive to be the link between the upstream and downstream chain groups all over the world through our technology and industrial value Moreover, we are actively involved in various R&D projects implemented both internally and in collaboration.
We are devoted to delivering the highest quality products and premium services that meet the needs and demands of our customers.
Become an innovative and breakthrough international biomedical company. Partner with worldwide experts and partners to form a versatile and competitive team.
Act as a focal point to support the domestic stockpile of raw materials.
Inject new energy into Taiwan's biomedical industry using the innovative and prosperous nature of research and development. Improve the industry's environment and attain international prestige.